Guideline | Domain #1: scope and purpose | Domain #2: stakeholder involvement | Domain #3: rigor of development | Domain #4: clarity of presentation | Domain #5: applicability | Domain #6: editorial independence | Overall assessment | Recommendation |
---|---|---|---|---|---|---|---|---|
Alberta Health Services | 61% | 35% | 83% | 63% | 0% | 75% | 58% | Recommended |
American Cancer Society | 33% | 6% | 7% | 46% | 4% | 8% | 8% | Not recommended |
American Society of Clinical Oncology | 44% | 36% | 15% | 75% | 23% | 46% | 42% | Not recommended |
Association of Community Cancer Centers | 19% | 36% | 2% | 75% | 4% | 0% | 17% | Not recommended |
Commission on Cancer | 19% | 33% | 12% | 88% | 19% | 0% | 33% | Not recommended |
Comprehensive Cancer Center of the Netherlands | 69% | 75% | 56% | 96% | 38% | 42% | 67% | Recommended |
International Myeloma Foundation | 56% | 42% | 17% | 63% | 21% | 96% | 42% | Not recommended |
Institute of Medicine | 22% | 42% | 12% | 92% | 38% | 38% | 50% | Not recommended |
LIVESTRONG | 33% | 22% | 10% | 96% | 31% | 0% | 33% | Not recommended |
National Breast and Ovarian Cancer Centre | 28% | 58% | 26% | 46% | 0% | 63% | 33% | Not recommended |
National Comprehensive Cancer Network | 72% | 58% | 26% | 67% | 31% | 42% | 50% | Not recommended |
National Coalition for Cancer Survivorship/Institute of Medicine/Lance Armstrong Foundation/National Cancer Institute | 92% | 61% | 18% | 63% | 52% | 0% | 58% | Recommended |
National Cancer Institute Community Cancer Centers Program | 56% | 42% | 17% | 88% | 40% | 29% | 58% | Recommended |
National Collaborating Centre for Cancer | 19% | 86% | 69% | 79% | 40% | 29% | 58% | Recommended |
President’s Cancer Panel | 11% | 92% | 7% | 92% | 15% | 0% | 25% | Not recommended |
National Health Service | 31% | 39% | 5% | 42% | 0% | 0% | 25% | Not recommended |